Common Shares Outstanding: The number of class A shares currently held by investors.
XTL Biopharmaceuticals Ltd. (XTLB) had Common Shares Outstanding of 8.81M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$1.99M |
|
$0.22M |
|
$7.29M |
|
$9.28M |
|
$2.47M |
|
-- |
|
$1.10M |
|
$3.56M |
|
$5.72M |
|
$-1.36M |
|
$5.72M |
|
|
Common Shares Outstanding |
8.81M |
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|